Your Sunday US Briefing: Shangri-la Handshake, Big Rate Decisions
Hello from New York, where we’re looking to fill the hole left by last week’s Succession finale. Back
2023-06-04 23:16
The S&P 500 finally broke through a key level. Now what?
The S&P 500 index on Friday closed at its highest level in almost a year. But that doesn't mean that stocks are poised for a bull run just yet.
2023-06-04 20:25
Austria’s Socialists Pick New Party Chief After Divisive Battle
Hans Peter Doskozil emerged victorious from a tumultuous leadership race within Austria’s opposition Socialist Party, pledging to shield
2023-06-03 23:29
Brazil poultry lobby sees little risk of nationwide export ban over bird flu
By Ana Mano SAO PAULO Revised trade accords with most of Brazil's trade partners, including China, make it
2023-06-03 09:21
Surging US megacap stocks leave some wondering when to cash out
By Lewis Krauskopf NEW YORK As the U.S. stock market continues its climb, investors holding shares of the
2023-06-03 05:29
EQT Nears Deal for Vet Drugmaker Dechra Pharmaceuticals
EQT AB agreed to buy Dechra Pharmaceuticals Plc for about £4.46 billion ($5.6 billion), negotiating a lower price
2023-06-02 14:48
Biden Plans to Tap Mandy Cohen for CDC Director, Replacing Walensky
President Joe Biden intends to nominate Mandy Cohen, North Carolina’s former health secretary who led the state’s response
2023-06-02 06:25
Rishi Sunak Refuses to Hand Over WhatsApp Texts to UK’s Covid Inquiry
Rishi Sunak’s administration refused a demand from the UK’s Covid-19 inquiry to hand over former Prime Minister Boris
2023-06-02 00:54
Little-Known Lung Infection Grabs Limelight From Covid, RSV
A little-known respiratory virus is grabbing the limelight from Covid-19 and RSV after cases surged earlier this year,
2023-06-01 21:51
Larry Summers Sees UK Recession After ‘Historic Error’ on Brexit
Larry Summers has said he would be “very surprised” if the UK gets through the next two years
2023-06-01 16:54
Astra Drops Bowel Disease Drug Program After Delays
AstraZeneca Plc abandoned the development of a medicine in advanced tests called brazikumab for inflammatory bowel diseases like
2023-06-01 15:00
J&J’s $8.9 Billion Talc Deal Faces Key Test in Oakland Trial
Johnson & Johnson’s first jury trial in nearly two years over allegations that its talc-based baby powder causes
2023-06-01 06:16